Pmv Pharmaceuticals Inc (PMVP) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.50 (+2.74%), Market cap $0.07B, 52-week low–high $0.87 ~ $1.80.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
Financial statements, price targets, institutional (13F) holdings and related news for Pmv Pharmaceuticals Inc are updated in real time on BlackAll Trade.
Pmv Pharmaceuticals Inc trades at $1.50 (+2.74%). Real-time quotes and charts are available on BlackAll Trade.
Pmv Pharmaceuticals Inc has a market cap of about $0.07B.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States